PMC:7253235 / 1231-1361 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"41","span":{"begin":8,"end":30},"obj":"Disease"},{"id":"42","span":{"begin":35,"end":41},"obj":"Disease"}],"attributes":[{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"MESH:D002318"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"risk of cardiovascular disease and cancer. Immunomodulatory therapies used to treat cytokine release syndrome secondary to anti-ca"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":84,"end":92},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"risk of cardiovascular disease and cancer. Immunomodulatory therapies used to treat cytokine release syndrome secondary to anti-ca"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T12","span":{"begin":8,"end":30},"obj":"Disease"},{"id":"T13","span":{"begin":35,"end":41},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0004995"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"risk of cardiovascular disease and cancer. Immunomodulatory therapies used to treat cytokine release syndrome secondary to anti-ca"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T8","span":{"begin":8,"end":30},"obj":"Phenotype"},{"id":"T9","span":{"begin":35,"end":41},"obj":"Phenotype"},{"id":"T10","span":{"begin":84,"end":109},"obj":"Phenotype"}],"attributes":[{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0001626"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"risk of cardiovascular disease and cancer. Immunomodulatory therapies used to treat cytokine release syndrome secondary to anti-ca"}